The comparison of EGFR-TKI failure modes and subsequent management between exon 19 deletion and exon 21 L858R mutation in advanced non-small-cell lung cancer

Background: Advanced non-small-cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 19 deletion (19 Del) and exon 21 L858R mutation (L858R) might be distinct diseases. Therefore, it is necessary to take EGFR mutation subgroups into consideration for making choices of subsequent...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Cancer
Hauptverfasser: Zhang, Yaxiong, Chen, Gang, Chen, Xi, Fang, Wenfeng, Gao, Fei, Yang, Yunpeng, Zhao, Yuanyuan, Ma, Yuxiang, Hong, Shaodong, Zhang, Zhonghan, Miao, Siyu, Wu, Manli, Huang, Xiaodan, Luo, Youli, Zhou, Cong, Gong, Run, Huang, Yan, Chen, Likun, Zhou, Ningning, Zhao, Hongyun, Zhang, Li
Format: Artigo
Sprache:Inglês
Veröffentlicht: Ivyspring International Publisher 2017
Schlagworte:
Research Paper
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5556650/
https://ncbi.nlm.nih.gov/pubmed/28819384
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.19867
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge